Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice
- PMID: 20086049
- PMCID: PMC4050966
- DOI: 10.1096/fj.09-136945
Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 mice
Abstract
Experience in complex environments induces numerous forms of brain plasticity, improving structure and function. It has been long debated whether brain plasticity can be induced under neuropathological conditions, such as Alzheimer's disease (AD), to an extent that would reduce neuropathology, rescue brain structure, and restore its function. Here we show that experience in a complex environment rescues a significant impairment of hippocampal neurogenesis in transgenic mice harboring familial AD-linked mutant APPswe/PS1DeltaE9. Proliferation of hippocampal cells is enhanced significantly after enrichment, and these proliferating cells mature to become new neurons and glia. Enhanced neurogenesis was accompanied by a significant reduction in levels of hyperphosphorylated tau and oligomeric Abeta, the precursors of AD hallmarks, in the hippocampus and cortex of enriched mice. Interestingly, enhanced expression of the neuronal anterograde motor kinesin-1 was observed, suggesting enhanced axonal transport in hippocampal and cortical neurons after enrichment. Examination of synaptic physiology revealed that environmental experience significantly enhanced hippocampal long-term potentiation, without notable alterations in basal synaptic transmission. This study suggests that environmental modulation can rescue the impaired phenotype of the Alzheimer's brain and that induction of brain plasticity may represent therapeutic and preventive avenues in AD.
Figures









Similar articles
-
Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.Brain Pathol. 2016 Jan;26(1):62-74. doi: 10.1111/bpa.12255. Epub 2015 May 7. Brain Pathol. 2016. PMID: 25763997 Free PMC article.
-
Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.J Neurosci Res. 2010 Aug 1;88(10):2103-17. doi: 10.1002/jnr.22387. J Neurosci Res. 2010. PMID: 20209626 Free PMC article.
-
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.Biochim Biophys Acta. 2014 Sep;1842(9):1556-66. doi: 10.1016/j.bbadis.2014.05.025. Epub 2014 Jun 2. Biochim Biophys Acta. 2014. PMID: 24887203
-
Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?Rev Neurosci. 2011;22(4):373-402. doi: 10.1515/RNS.2011.035. Epub 2011 Jul 6. Rev Neurosci. 2011. PMID: 21732714 Review.
-
Neurogenesis and Alzheimer's disease: at the crossroads.Exp Neurol. 2010 Jun;223(2):267-81. doi: 10.1016/j.expneurol.2009.08.009. Epub 2009 Aug 19. Exp Neurol. 2010. PMID: 19699201 Free PMC article. Review.
Cited by
-
Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease.Front Cell Dev Biol. 2020 Sep 16;8:860. doi: 10.3389/fcell.2020.00860. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33042988 Free PMC article. Review.
-
Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.Neural Plast. 2015;2015:781731. doi: 10.1155/2015/781731. Epub 2015 Apr 2. Neural Plast. 2015. PMID: 25922768 Free PMC article.
-
Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer's disease.J Neuroinflammation. 2020 Sep 15;17(1):271. doi: 10.1186/s12974-020-01935-w. J Neuroinflammation. 2020. PMID: 32933545 Free PMC article.
-
Alzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared Mechanisms.Front Neurosci. 2016 May 3;10:178. doi: 10.3389/fnins.2016.00178. eCollection 2016. Front Neurosci. 2016. PMID: 27199641 Free PMC article. Review.
-
Examination of Longitudinal Alterations in Alzheimer's Disease-Related Neurogenesis in an APP/PS1 Transgenic Mouse Model, and the Effects of P33, a Putative Neuroprotective Agent Thereon.Int J Mol Sci. 2022 Sep 8;23(18):10364. doi: 10.3390/ijms231810364. Int J Mol Sci. 2022. PMID: 36142277 Free PMC article.
References
-
- Rosen W. G., Mohs R. C., Davis K. L. A new rating scale for Alzheimer’s disease. Am J Psych. 1984;141:1356–1364. - PubMed
-
- Selkoe D. J. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–766. - PubMed
-
- Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J., Ashe K. H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 2005;8:79–84. - PubMed
-
- Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med. 2008;14:837–842. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical